<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4898">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01953302</url>
  </required_header>
  <id_info>
    <org_study_id>24011983</org_study_id>
    <nct_id>NCT01953302</nct_id>
  </id_info>
  <brief_title>Modified &quot;Open Intraperitoneal Mesh&quot; Technique of Incisional Ventral Hernia Repair</brief_title>
  <official_title>Modified &quot;Open Intraperitoneal Mesh&quot; Technique of Incisional Ventral Hernia Repair - a Pilot Study on 55 Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Varazdin General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Varazdin General Hospital</source>
  <oversight_info>
    <authority>Croatia: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ventral hernias, primary and recurrent, are major surgical challenge. We aim to investigate
      efficacy of modified technique of ventral hernias repair: an &quot;open intraperitoneal mesh&quot;
      technique.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2010</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>number/frequency of early postoperative complications (wound infections, seroma, hematoma)</measure>
    <time_frame>four weeks after the surgery</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>postoperative hernia recurrence</measure>
    <time_frame>up to 36 months after the surgery</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Incisional Ventral Hernia</condition>
  <condition>Recurrent Ventral Hernia</condition>
  <arm_group>
    <arm_group_label>modified &quot;open mesh technique&quot;</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>We performed an &quot;open&quot; intraperitoneal mesh technique in all patients: we placed surgical mesh of appropriate size intraperitoneally with transfascial fixation and drainage.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>modified &quot;open mesh technique&quot;</intervention_name>
    <description>We positioned mesh intraperitoneally so it can provide adequate mechanical support to the weakened abdominal wall. We also preserved hernia sack to conceal the mesh.</description>
    <arm_group_label>modified &quot;open mesh technique&quot;</arm_group_label>
    <other_name>Proceed Surgical Mesh</other_name>
    <other_name>VycrilTM,2-0 resorbing sutures</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients aged 18 years or older

          -  American Society of Anesthesiologists physical status I, II, III

        Exclusion Criteria:

          -  refusal of the patients to give informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ranko Stare, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Varazdin General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Anita Lukic, MD, PhD</last_name>
    <phone>00385958236723</phone>
    <email>lukic.anita@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alen Pajtak, MD</last_name>
    <phone>00385981918289</phone>
    <email>alen@dvasadva.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Varazdin General Hospital</name>
      <address>
        <city>Varazdin</city>
        <zip>HR-42000</zip>
        <country>Croatia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anita Lukic, MD, PhD</last_name>
      <phone>00385958236723</phone>
      <email>lukic.anita@yahoo.com</email>
    </contact>
    <contact_backup>
      <last_name>Alen Pajtak, MD</last_name>
      <phone>00385981918289</phone>
      <email>alen@dvasadva.net</email>
    </contact_backup>
    <investigator>
      <last_name>Alen Pajtak, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ranko Stare, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandra Skorjanec, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ivica Biskup, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Krunoslav Hrzenjak, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anita Lukic, MD, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Croatia</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>April 24, 2014</lastchanged_date>
  <firstreceived_date>September 21, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ventral hernia</keyword>
  <keyword>infection</keyword>
  <keyword>hematoma</keyword>
  <keyword>seroma</keyword>
  <keyword>recurrence</keyword>
  <keyword>mesh technique</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Ventral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
